Ganciclovir-Resistant Cytomegalovirus Infections among Lung Transplant Recipients Are Associated with Poor Outcomes despite Treatment with Foscarnet-Containing Regimens

Lignende værker

• Prospective, Observational Study of Voriconazole Therapeutic Drug Monitoring among Lung Transplant Recipients Receiving Prophylaxis: Factors Impacting Levels of and Associations between Serum Troughs, Efficacy, and Toxicity
  af: Mitsani, Dimitra, et al.
  Udgivet: (2012)
• Combined ganciclovir and foscarnet in pediatric cytomegalovirus retinitis.
  af: Sastry, S. M., et al.
  Udgivet: (1996)
• Posaconazole Serum Concentrations among Cardiothoracic Transplant Recipients: Factors Impacting Trough Levels and Correlation with Clinical Response to Therapy
  af: Shields, Ryan K., et al.
  Udgivet: (2011)
• Synergistic effect of ganciclovir and foscarnet on cytomegalovirus replication in vitro.
  af: Manischewitz, J F, et al.
  Udgivet: (1990)
• Recombinant Phenotyping of Cytomegalovirus UL54 Mutations That Emerged during Cell Passages in the Presence of either Ganciclovir or Foscarnet
  af: Gilbert, Christian, et al.
  Udgivet: (2011)